Various media have reported on studies addressing COVID-19 to be undertaken by several research centres in Catalonia. Among the groups involved is IRB Barcelona’s Structural Bioinformatics and Network Biology Lab, headed by Patrick Aloy. IRB Barcelona is one of eight research centres chosen by the European Commission to study new approaches to treat and diagnose COVID-19 and thus halt the spread of the virus.
Various media, including El Progreso, the Diario de Pontevedra and Biotech Spain, have echoed the Barcelona Biomed Conference. From November 13 to 15, more than twenty experts shared the advances made in 3D genomics, a field that is expected/has the capacity to unravel the underlying causes of many diseases. Modesto Orozco, leader of the Molecular Modelling and Bioinformatics group at IRB Barcelona, was a co-organiser of the event.